First malaria vaccine receives positive scientific opinion from EMA
Mosquirix to be used for vaccination of young children, together with established antimalarial interventions
28-Jul-2015 -
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive scientific opinion for Mosquirix (Plasmodium falciparum and hepatitis B vaccine), for use outside the European Union (EU). The malaria vaccine Mosquirix, also known as RTS,S/AS01, was ...
hepatitis B
Plasmodium falciparum
vaccines